Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

GLP-1glp-1abdominoplastyperioperativeaesthetic-plastic-surgery

Letter questions study of preoperative GLP-1 agonists in abdominoplasty patients

Correspondence in Aesthetic Plastic Surgery responds to a prospective single-center study of thromboinflammatory markers in surgical patients on incretin drugs.

MH
By Maren Holt · Senior Reporter, GLP-1
Oct 14 20:00 ETSource: Aesthetic plastic surgery

The wire

  1. 01Nosratzehi and colleagues published a letter to the editor on a prospective monocentric study of preoperative GLP-1 receptor agonists and thromboinflammatory markers in abdominoplasty patients.
  2. 02Surgeons and prescribers are still working out perioperative management for patients on incretin drugs, and journal correspondence shapes how the underlying data get read.
  3. 03Only the letter's title is available here; the specific methodological objections and any author reply are not detailed.

From the source

Letter to the Editor on "Preoperative GLP-1 Receptor Agonists and Thromboinflammatory Markers in Patients Undergoing Abdominoplasty: A Prospective Monocentric Study"

Aesthetic plastic surgery · 2026 Oct 15 · Nosratzehi M, Nosratzehi S, Rostami M et al.

Read at pubmed.ncbi.nlm.nih.gov
PeptiPrescribed peptides from $99/moSee all →